Lu Chen
Impact in
- Immunology top 1%
- interferon and immune responses
- Immune cells in cancer
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Immunology 47
- Immune cells in cancer 17
- Immune Cell Function and Interaction 7
- IL-33, ST2, and ILC Pathways 7
-
- Cancer-related molecular mechanisms research 17
- MicroRNA in disease regulation 12
- Co-authors
- Xiang Zhou (2 shared papers)Zhengfan Jiang (2 shared papers)Wenxiang Sun (2 shared papers)Fuping You (2 shared papers)Danying Chen (1 shared paper)Yang Li (1 shared paper)Zhonghe Zhai (1 shared paper)Huihui Chen (1 shared paper)
- Journals
- Cell Death and Disease (5 papers)Frontiers in Immunology (4 papers)The Journal of Immunology (4 papers)Oncotarget (4 papers)Cancer Letters (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Lu Chen
121 papers receiving 5.0k citations
Lu Chen's Hit Papers
Peers
Comparison fields: 5 of 124
- Immunology 1.9k
- Cancer Research 1.2k
- Molecular Biology 2.6k
- Infectious Diseases 515
- Oncology 662
Countries citing papers authored by Lu Chen
This map shows the geographic impact of Lu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Chen more than expected).
Fields of papers citing papers by Lu Chen
This network shows the impact of papers produced by Lu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Chen. The network helps show where Lu Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 129 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization Hit paper breakdown → | 2009 | 759 |
| 2 | 2012 | 403 | |
| 3 | 2019 | 343 | |
| 4 | 2011 | 307 | |
| 5 | 2017 | 200 | |
| 6 | 2022 | 168 | |
| 7 | 2008 | 153 | |
| 8 | 2020 | 148 | |
| 9 | 2020 | 119 | |
| 10 | 2021 | 109 | |
| 11 | 2022 | 84 | |
| 12 | 2021 | 81 | |
| 13 | 2019 | 76 | |
| 14 | 2022 | 74 | |
| 15 | 2023 | 73 | |
| 16 | 2021 | 70 | |
| 17 | 2011 | 70 | |
| 18 | 2002 | 68 | |
| 19 | 2022 | 65 | |
| 20 | 2019 | 62 |
About Lu Chen
Lu Chen is a scholar working on Immunology, Cancer Research, Molecular Biology, Oncology and Pathology and Forensic Medicine, having authored 129 papers that have together received 5.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (17 papers), Immune cells in cancer (17 papers), Circular RNAs in diseases (15 papers), MicroRNA in disease regulation (12 papers), RNA modifications and cancer (11 papers), Extracellular vesicles in disease (11 papers), Immune Cell Function and Interaction (7 papers) and IL-33, ST2, and ILC Pathways (7 papers). The work is most often cited by research in Immunology (1.9k citations), Cancer Research (1.2k citations), Molecular Biology (2.6k citations), Infectious Diseases (515 citations) and Oncology (662 citations). Lu Chen has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Xiang Zhou, Zhengfan Jiang, Wenxiang Sun, Fuping You, Danying Chen, Yang Li, Zhonghe Zhai, Huihui Chen, Yi Zhou and Dawei Rong. Their work appears in journals such as Cell Death and Disease, Frontiers in Immunology, The Journal of Immunology, Oncotarget and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.